Showing results (91-100 of 170) with videos related to
Sort By:
Pageof 17
Urology|February 6, 2026
Diagnostic performance of urinary biomarker tests in detecting bladder cancer: A systematic review, meta-analysis, and network meta-analysisFernando Siguencia, John Heard, Steven M Smith, et al.Journal of the National Medical Association|July 4, 2008
Knowledge and attitudes of primary care physicians regarding prostate cancer screeningJohn Pendleton, Robert Whit Curry, Ali Kaserian, et al.The Prostate|May 10, 2008
Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiationWengang Cao, Saif Yacoub, Kathleen T Shiverick, et al.The Journal of Urology|November 11, 2005
Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancerDan Leibovici, Ashish M Kamat, Curtis A Pettaway, et al.Oncotarget|November 19, 2016
A microRNA biomarker panel for the non-invasive detection of bladder cancerVirginia Urquidi, Mandy Netherton, Evan Gomes-Giacoia, et al.Cancer Gene Therapy|July 24, 2002
Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expressionJain-Hua Zhou, Charles J Rosser, Motoyoshi Tanaka, et al.The Journal of Urology|May 29, 2003
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostateCharles J Rosser, Lawrence B Levy, Deborah A Kuban, et al.Diagnostic Pathology|November 13, 2014
Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signatureGe Zhang, Evan Gomes-Giacoia, Yunfeng Dai, et al.Histopathology|July 20, 2010
Smoothelin immunohistochemistry is a useful adjunct for assessing muscularis propria invasion in bladder carcinomaIan M Bovio, Samer Z Al-Quran, Charles J Rosser, et al.Journal of Translational Medicine|February 3, 2016
A multiplex immunoassay for the non-invasive detection of bladder cancerYoshiko Shimizu, Hideki Furuya, Peter Bryant Greenwood, et al.Pageof 17